Lisa Pisano, a terminally ill patient in New Jersey, underwent a first-of-its-kind double surgery at NYU Langone Health which included a heart pump implant and a gene-edited pig kidney transplant.

The pig kidney, utilized under the FDA's 'compassionate use' program, is functioning well with no rejection signs, showcasing the procedure's potential.

While the procedure's immediate success is promising, it raises questions about long-term viability, safety, and ethical considerations in xenotransplantation.

The success of this surgery provides hope against organ shortages and may be a landmark in the evolution of organ transplant methods.

Further clinical trials with more participants are essential to potentially standardize xenotransplantation as an approved medical procedure.

The patient's family has expressed deep appreciation for the medical team, and there is optimism for Lisa Pisano's improved quality of life and time with her grandchildren.